08
Jan 2019
Underactive thyroid patients missing out on vital drug following 60-fold price rise
According to recent research, thousands of female patients are going without a vital thyroid drug due to a cancellation in prescriptions following a 60-fold price increase. The cost to the NHS of a four week course of liothyronine, which is used to treat hypothyroidism increased from under £4.50 to £258.19 in 2016 after the manufacturer…
